Phenotypic drug screening and target validation for improved personalized therapy reveal the complexity of phenotype-genotype correlations in clear cell renal cell carcinoma1Present address: Department of Urology, University Hospital Frankfurt, Germany.2Equal contributions.-Reference-Cited by-同舟云学术

Phenotypic drug screening and target validation for improved personalized therapy reveal the complexity of phenotype-genotype correlations in clear cell renal cell carcinoma1Present address: Department of Urology, University Hospital Frankfurt, Germany.2Equal contributions.

Published:2014-08 Issue:6 Volume:32 Page:877-884
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Schneider Meike,Schüler Julia,Höfflin Rouven,Korzeniewski Nina,Grüllich Carsten,Roth Wilfried,Teber Dogu,Hadaschik Boris,Pahernik Sascha,Hohenfellner Markus,Duensing Stefan

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference22 articles.

1. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

2. Current treatment considerations in metastatic renal cell carcinoma;Haddad;Curr Treat Options Oncol,2012

3. Novel agents and approaches for advanced renal cell carcinoma;Figlin;J Urol,2012

4. Systemic treatment options for untreated patients with metastatic clear cell renal cancer;Molina;Semin Oncol,2013

5. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas;Schmidt;Nat Genet,1997

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities;Frontiers in Oncology;2022-05-10

2. Whole-Exome Sequencing Identifies the VHL Mutation (c.262T > C, p.Try88Arg) in Non-Obstructive Azoospermia-Associated Cystic Renal Cell Carcinoma;Current Oncology;2022-03-28

3. Fragment-Based Phenotypic Lead Discovery To Identify New Drug Seeds That Target Infectious Diseases;ACS Chemical Biology;2021-10-26

4. Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery;Biomedicines;2021-05-31

5. Screening of metabolic modulators identifies new strategies to target metabolic reprogramming in melanoma;Scientific Reports;2021-02-23